We and others have shown that individuals with constitutive deficiency in the BER protein MBD4, which corrects T:G mismatches, develop tumours with a very high CpG > TpG mutation burden and a predominant mutational signature that is very similar to SBS1 [7–9]. This evidence concerns the gene MBD4 and neoplasm.